185 related articles for article (PubMed ID: 7507125)
1. B cell activation and human immunodeficiency virus infection. V. Phenotypic and functional alterations in CD5+ and CD5- B cell subsets.
Indraccolo S; Mion M; Zamarchi R; Veronesi A; Veronese ML; Panozzo M; Betterle C; Barelli A; Borri A; Amadori A
J Clin Immunol; 1993 Nov; 13(6):381-8. PubMed ID: 7507125
[TBL] [Abstract][Full Text] [Related]
2. CD5+ B lymphocytes in HIV infection: relationship to immunological progression of disease.
Sampalo A; López-Gómez M; Jiménez-Alonso J; Ortiz F; Samaniego F; Garrido F
Clin Immunol Immunopathol; 1993 Mar; 66(3):260-8. PubMed ID: 7679344
[TBL] [Abstract][Full Text] [Related]
3. The relationship between CD5+ and CD5- B cells, immunoglobulin-secreting cells (IgSC), and CD4 T cells in human immunodeficiency virus (HIV) infection.
Spira TJ; Jones B; Ibegbu C; Lee F; Holmes R; Nahmias AJ
Ann N Y Acad Sci; 1992 May; 651():591-3. PubMed ID: 1376087
[No Abstract] [Full Text] [Related]
4. The effect of combination antiretroviral therapy on CD5 B- cells, B-cell activation and hypergammaglobulinaemia in HIV-1-infected patients.
Redgrave BE; Stone SF; French MA; Krueger R; James IR; Price P
HIV Med; 2005 Sep; 6(5):307-12. PubMed ID: 16156877
[TBL] [Abstract][Full Text] [Related]
5. Lymphokine production by B cells from normal and HIV-infected individuals.
Kehrl JH; Rieckmann P; Kozlow E; Fauci AS
Ann N Y Acad Sci; 1992 May; 651():220-7. PubMed ID: 1376041
[TBL] [Abstract][Full Text] [Related]
6. Anti-phospholipid antibodies and CD5+ B cells in HIV infection.
Grünewald T; Burmester GR; Schüler-Maué W; Hiepe F; Buttgereit F
Clin Exp Immunol; 1999 Mar; 115(3):464-71. PubMed ID: 10193419
[TBL] [Abstract][Full Text] [Related]
7. A CD3+CD8+ T cell population lacking CD5 antigen expression is expanded in peripheral blood of human immunodeficiency virus-infected patients.
Indraccolo S; Mion M; Zamarchi R; Coppola V; Calderazzo F; Amadori A; Chieco-Bianchi L
Clin Immunol Immunopathol; 1995 Dec; 77(3):253-61. PubMed ID: 7586735
[TBL] [Abstract][Full Text] [Related]
8. HIV-induced, HIV-specific in vitro antibody response by B-cells from HIV-seropositive individuals.
Delfraissy JF; Wallon C; Boué F; Goujard C; Barré-Sinoussi F; Galanaud P
AIDS; 1992 Jan; 6(1):55-63. PubMed ID: 1371925
[TBL] [Abstract][Full Text] [Related]
9. Serial study of CD5+ and CD5- B cell subpopulations in 335 HIV seropositive patients.
Vuillier F; Scott-Algara D; Tortevoye P; Pialoux G; Dighiero G
Clin Exp Immunol; 1991 Sep; 85(3):476-80. PubMed ID: 1716542
[TBL] [Abstract][Full Text] [Related]
10. B-cell subsets and platelet counts in HIV-1 seropositive subjects.
Kouri YH; Basch RS; Karpatkin S
Lancet; 1992 Jun; 339(8807):1445-6. PubMed ID: 1376384
[TBL] [Abstract][Full Text] [Related]
11. Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity.
Martínez-Maza O; Crabb E; Mitsuyasu RT; Fahey JL; Giorgi JV
J Immunol; 1987 Jun; 138(11):3720-4. PubMed ID: 2953790
[TBL] [Abstract][Full Text] [Related]
12. HIV-1-specific B cell activation. A major constituent of spontaneous B cell activation during HIV-1 infection.
Amadori A; Zamarchi R; Ciminale V; Del Mistro A; Siervo S; Alberti A; Colombatti M; Chieco-Bianchi L
J Immunol; 1989 Oct; 143(7):2146-52. PubMed ID: 2476498
[TBL] [Abstract][Full Text] [Related]
13. Subpopulations of T and B cells in perinatally HIV-infected and noninfected age-matched children compared with those in adults.
Ibegbu C; Spira TJ; Nesheim S; Mendez H; Lee F; Polliotti B; Caba J; Nahmias A
Clin Immunol Immunopathol; 1994 Apr; 71(1):27-32. PubMed ID: 7511082
[TBL] [Abstract][Full Text] [Related]
14. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
[TBL] [Abstract][Full Text] [Related]
15. Anti-islet cell and anti-insulin antibody production by CD5+ and CD5- B lymphocytes in IDDM.
Muñoz A; Gallart T; Usac EF; Fernández-Alvarez J; Viñas O; Somoza N; Barceló J; Gomis R
Diabetologia; 1995 Jan; 38(1):62-72. PubMed ID: 7538087
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic characteristics of B cells in Behçet's disease: increased activity in B cell subsets.
Ekşioglu-Demiralp E; Kibaroglu A; Direskeneli H; Yavuz S; Karsli F; Yurdakul S; Yazici H; Akoglu T
J Rheumatol; 1999 Apr; 26(4):826-32. PubMed ID: 10229403
[TBL] [Abstract][Full Text] [Related]
17. Feedback suppression of normal and leukemic B cell colony growth by CD5+ B cells.
Fernandez LA; MacSween JM; Robson DA
Ann N Y Acad Sci; 1991; 628():379-81. PubMed ID: 1712559
[No Abstract] [Full Text] [Related]
18. B-1 cells in systemic autoimmune responses: IgM+, Fc epsilon Rdull B cells are lost during chronic graft-versus-host disease but not in murine AIDS or collagen-induced arthritis.
Iciek LA; Waldschmidt TJ; Griffiths MM; Brooks KH
Immunol Invest; 1994 Aug; 23(4-5):293-311. PubMed ID: 7525472
[TBL] [Abstract][Full Text] [Related]
19. Surface immunoglobulin ligands and cytokines differentially affect proliferation and antibody production by human CD5+ and CD5- B lymphocytes.
Nawata Y; Stall AM; Herzenberg LA; Eugui EM; Allison AC
Int Immunol; 1990; 2(7):603-14. PubMed ID: 1703783
[TBL] [Abstract][Full Text] [Related]
20. Identification of two distinct CD5- B cell subsets from human tonsils with different responses to CD40 monoclonal antibody.
Dono M; Zupo S; Masante R; Taborelli G; Chiorazzi N; Ferrarini M
Eur J Immunol; 1993 Apr; 23(4):873-81. PubMed ID: 7681401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
